HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Volume 20, No. 5, May 2016 – Healthcare Systems & Policies in Asia       » Understanding Healthcare Policies in the Philippines: Cancer Care       » Young Innovators under 35       » Healthcare Cost Effectiveness in Singapore       » ASLAN Pharmaceuticals Opens China Office       » A Journey Inside the Human Body       » Treatment Brings New Hope for Patients Suffering From Fatal Lung Disease      
EYE ON CHINA
Zhifei Biological's vaccine approved for clinical test
Chongqing Zhifei Biological Product Co., Ltd. got the approval documents for clinical test of its Mycobacterium Vaccae for Injection (Vaccae) from the SFDA (State Food and Drug Administration).

According to the approval documents, the product could be used as a biological product in Phase III clinical test for the prevention of tuberculosis.

As a product independently-developed and sold by Zhifei Biological, Vaccae could be used as adjuvant drug for the chemotherapy of tuberculosis. The product generated income of CNY 36.64 million, CNY 46.01 million and CNY 41.36 million in 2010, 2011 and the first three quarters of 2012, respectively, with an average gross profit margin of about 89.24%.

According to the 2012 global tuberculosis report issued by the WHO (World Health Organization), a total of 13 vaccines for the prevention of tuberculosis in the world have entered clinical research stage and only India's M.indicus pranii (MIP),which is still being developed, has entered Phase III clinical test stage. According to Zhifei Biological, the approval of the Vaccae to be used in Phase III clinical test means China has caught up with other countries in the study in this field.

Click here for the complete issue.

NEWS CRUNCH  
news World Immunisation Week 2016
news IoT Asia 2016 Delivers Actionable Solutions for a Sustainable IoT Ecosystem in Asia
news Lite-On presents a new Biomedical Research and Development Centre in Singapore
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
APBN Editorial Calendar 2016
January:
Guest Editorial - Biotechnology In Korea
February:
Guest Editorial - Biomedical Research Governance
March:
Guest Editorial - Life-Saving Opportunities: A Guide to Regenerative Medicine
April:
Leading-Edge ONCOLOGY
May:
Healthcare Systems & Policies in Asia
June:
Medical Devices and Digital Health Technology
July:
Water Technology
August:
Guest Editorial - Antibody Informatics In Japan
September:
Infectious Diseases
October:
Medical Tourism
November:
Biomedical Imaging Technology
December:
Food Technology
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» Editorial Enquiries: biotech_edit@wspc.com
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   Ms PoPo Kwok or Ms Sok Ching Lim/td>
Copyright© 2015 World Scientific Publishing Co Pte Ltd  •  Privacy Policy